Carcinoma: all 6,719 studies
Page 63 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid CancerTerminatedNCT00647140Phase 2
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisCompletedNCT00646100Phase 4
- Axillary Reverse Mapping for Invasive Carcinoma of the BreastCompletedNCT00645541Phase 1
- Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) PatientsStatus unknownNCT00644020
- A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous CarcinomaStatus unknownNCT00642239Phase 4
- Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970Status unknownNCT00639652
- Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric CarcinomaStatus unknownNCT00639522Phase 1
- N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing ChemotherapyTerminatedNCT00637624Not applicable
- A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast CancerCompletedNCT00637481Phase 1
- Phase I Study of Vorinostat and Sorafenib in Advanced CancerCompletedNCT00635791Phase 1
- Phase II Trial to Evaluate Laparoscopic Surgery for Stage 0/I Rectal CarcinomaStatus unknownNCT00635466Phase 2
- Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular CarcinomaCompletedNCT00635323Phase 2
- Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell CarcinomaStatus unknownNCT00634777Not applicable
- Trial of E10A in Head and Neck CancerStatus unknownNCT00634595Phase 2
- Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung CancerTerminatedNCT00633568Phase 3
- Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial ChemoembolizationCompletedNCT00630240
- Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular CarcinomaCompletedNCT00629486Not applicable
- Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective StudyCompletedNCT00629421
- Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)WithdrawnNCT00627835Phase 1
- Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant MelanomaCompletedNCT00625768Phase 1
- Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsCompletedNCT00625456Phase 1
- Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell CarcinomaStatus unknownNCT00625352Phase 2
- Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.TerminatedNCT00622479Phase 1
- Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell CarcinomaCompletedNCT00620139
- Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00619541Phase 2
- Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell CarcinomaCompletedNCT00619268Phase 2
- TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT00618384Phase 2
- A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive CarcinomaCompletedNCT00613691Phase 1
- Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid TumorsStatus unknownNCT00610389Phase 2
- Tumor Registry of Advanced Renal Cell CarcinomaCompletedNCT00610012
- Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the BoneCompletedNCT00609934Phase 1/2
- Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)CompletedNCT00609401Phase 2
- Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00608361Phase 1
- MRI Study of BAY 43-9006 in Metastatic Renal Cell CarcinomaCompletedNCT00606866Phase 3
- Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCCStatus unknownNCT00606385Not applicable
- Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell CarcinomaWithdrawnNCT00605709Phase 2
- Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum ChemotherapyCompletedNCT00602277Phase 1
- Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.CompletedNCT00601185
- RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell CarcinomaWithdrawnNCT00601120Not applicable
- Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell CarcinomaCompletedNCT00596219Not applicable
- Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial CarcinomaCompletedNCT00595725Not applicable
- Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor ImagingCompletedNCT00594724Not applicable
- Photochemical Tissue BondingCompletedNCT00586040Phase 2
- Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in SituCompletedNCT00581750
- Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)CompletedNCT00581425Phase 4
- Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue SarcomaCompletedNCT00580320Phase 1
- Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
- Treatment of Advanced Renal Cell Carcinoma With QuinacrineWithdrawnNCT00574483Phase 2
- Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-VivoCompletedNCT00574392
- A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell CarcinomaCompletedNCT00571363Not applicable
- Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)CompletedNCT00570882Phase 2
- Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung CarcinomaTerminatedNCT00568906
- Phase III Study of PI-88 in Post-resection Hepatocellular CarcinomaTerminatedNCT00568308Phase 3
- Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.TerminatedNCT00565227Phase 1
- Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)Status unknownNCT00563927Not applicable
- Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)TerminatedNCT00563862Not applicable
- A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell CarcinomaCompletedNCT00563147Phase 1
- A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver CancerStatus unknownNCT00563095Not applicable
- Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T CellsTerminatedNCT00562666Phase 1
- Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative ResectionStatus unknownNCT00561522Phase 2/3
- Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00559455Phase 2
- Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00557024Phase 4
- TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular CarcinomaStatus unknownNCT00556803Phase 4
- Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell CarcinomaWithdrawnNCT00556205Phase 2
- Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00555334Phase 4
- Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular CarcinomaStatus unknownNCT00554905Phase 4
- Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line ChemotherapyWithdrawnNCT00551265Not applicable
- Optical Biopsy of Human Skin in Conjunction With Laser TreatmentCompletedNCT00540566
- Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP TrialCompletedNCT00540059
- Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary BladderCompletedNCT00539773Not applicable
- An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib TherapyWithdrawnNCT00538772
- Genetics of Women With Lobular Carcinoma in Situ of the BreastStatus unknownNCT00536718
- Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's DiseaseNo longer availableNCT00535080
- Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular CarcinomaCompletedNCT00534664Phase 1/2
- Sorafenib in Resected Non-small Cell Lung CarcinomaTerminatedNCT00532025Phase 2
- A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248CompletedNCT00531544Not applicable
- A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic MeningitisTerminatedNCT00527410Phase 1
- A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular CarcinomaCompletedNCT00524498Phase 2
- IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable DiseaseCompletedNCT00523159Phase 2
- Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular CarcinomaStatus unknownNCT00522405Phase 2/3
- Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCCTerminatedNCT00522249Phase 1/2
- UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaCompletedNCT00519688Phase 2
- Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With AntiangiogenesisStatus unknownNCT00518557Not applicable
- Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00517920Phase 2
- LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)CompletedNCT00516087Phase 1
- Curettage Versus Excision in Nodular and Superficial Basal Cell CarcinomasSuspendedNCT00515970Not applicable
- Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)WithdrawnNCT00515957Phase 1
- Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and NeckCompletedNCT00513383Phase 1
- Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic AnemiaCompletedNCT00513175
- Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)CompletedNCT00508664Phase 2
- Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.CompletedNCT00502034Phase 3
- Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels InvasionStatus unknownNCT00501813Phase 3
- Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid TumorsCompletedNCT00499135Phase 1
- Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCCCompletedNCT00496301Phase 2
- GH, IGF-I and Somatostatin Analogues in Hepatocellular CarcinomaCompletedNCT00495846Phase 2/3
- Different Regimens of Transarterial Chemoembolization for Hepatocellular CarcinomaCompletedNCT00493402Phase 3
- An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell CarcinomaCompletedNCT00492986Phase 3
- Dendritic Cell Vaccine for Head and Neck CancerWithdrawnNCT00492947Phase 1
- Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisCompletedNCT00491855Phase 1
- Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00490685Phase 2